BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rebelatto CLK, Senegaglia AC, Franck CL, Daga DR, Shigunov P, Stimamiglio MA, Marsaro DB, Schaidt B, Micosky A, de Azambuja AP, Leitão CA, Petterle RR, Jamur VR, Vaz IM, Mallmann AP, Carraro Junior H, Ditzel E, Brofman PRS, Correa A. Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial. Stem Cell Res Ther 2022;13:122. [PMID: 35313959 DOI: 10.1186/s13287-022-02796-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang F, Li Y, Wang B, Li J, Peng Z. The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials. Crit Care 2023;27:31. [PMID: 36670442 DOI: 10.1186/s13054-022-04287-4] [Reference Citation Analysis]
2 Chien C, Liu Y, Chang Y, Ma Y. Characterization of mesenchymal stem cells with augmented internalization of magnetic nanoparticles: The implication of therapeutic potential. Journal of Magnetism and Magnetic Materials 2022;564:170060. [DOI: 10.1016/j.jmmm.2022.170060] [Reference Citation Analysis]
3 Kirkham AM, Bailey AJ, Shorr R, Lalu MM, Fergusson DA, Allan DS. Systematic review and meta-analysis of randomized controlled trials of mesenchymal stromal cells to treat coronavirus disease 2019: is it too late? Cytotherapy 2022. [DOI: 10.1016/j.jcyt.2022.10.003] [Reference Citation Analysis]
4 Faizan MI, Chaudhuri R, Sagar S, Albogami S, Chaudhary N, Azmi I, Akhtar A, Ali SM, Kumar R, Iqbal J, Joshi MC, Kharya G, Seth P, Roy SS, Ahmad T. NSP4 and ORF9b of SARS-CoV-2 Induce Pro-Inflammatory Mitochondrial DNA Release in Inner Membrane-Derived Vesicles. Cells 2022;11:2969. [DOI: 10.3390/cells11192969] [Reference Citation Analysis]